.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Postersession

Postersession II

Appointment

Date: 26/09/2023

Time: 13:30 – 14:30

Location / Stream:

Foyer

Programme

Poster
P-2-1
Public health communication for vaccine trials: the VACCELERATE pan-European toolkit
Dr. Jon Salmanton-García (Cologne/ DE)
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
Poster
P-2-2
Research nurses in Europe: education paths and key tasks. Results from VACCELERATE
Dr. Jon Salmanton-García (Cologne/ DE)
Data Science and Bioresources
Poster
P-2-3
FAIRification of microbial OMICs data
Jannik Seidel (Tübingen/ DE)
Data Science and Bioresources
Poster
P-2-4
Genotyping the Transplant Cohort of the German Center for Infection Research (DZIF Tx-Cohort): from sample selection to a quality-controlled dataset
Dr. Bärbel Fösel (Neuherberg/ DE)
Data Science and Bioresources
Poster
P-2-5
Screening of a metagenomic fosmid library for active antimicrobial natural product gene clusters
Karin Martin (Jena/ DE)
Data Science and Bioresources
Poster
P-2-6
DZIF databases for pathogen genome sequences and associated metadata, based on the EnteroBase platform
Birgitta Päuker (Braunschweig/ DE)
Data Science and Bioresources
Poster
P-2-7
Geno2pheno: Recombination detection for HIV and HEV subtypes
Martin Pirkl (Cologne/ DE)
Data Science and Bioresources
Poster
P-2-8
Reconstruction, comparison and growth simulation of strain-specific metabolic computer models of Staphylococcus haemolyticus
Gwendolyn Gusak (Tübingen/ DE)
Data Science and Bioresources
Poster
P-2-9
Genome sequence-based screening for novel phosphonate producers
Alina Zimmermann (Braunschweig/ DE)
Data Science and Bioresources
Poster
P-2-10
Sustainability in health care sector – can we go greener?
Dr. Andrea Kühn-Steven (Oberschleißheim/ DE)
Data Science and Bioresources
Poster
P-2-11
IMS-TB: integrated molecular surveillance of tuberculosis in Germany to enhance public health
Dr. Thomas Kohl (Lübeck/ DE)
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
Poster
P-2-12
High relevance of Autopsy-based COVID-19 tissue biobanking in anti-SARS-CoV-2 vaccination research
Tilman Pfeffer (Heidelberg/ DE)
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
Poster
P-2-13
INCATE: Supporting innovators to fight drug-resistant infections
Dr. Ina-Kristin Behrens (Braunschweig/ DE)
Dr. Silke Alt (Braunschweig/ DE)
Antimicrobial Resistance
Poster
P-2-14
Development of BamA inhibitors to kill gram-negative pathogens
Prof. Dr. Till Schäberle (Giessen/ DE)
Antimicrobial Resistance
Poster
P-2-15
Fragment-based discovery of antibacterials against Acinetobacter baumannii
Dr. Simona Bianca (Munich/ DE)
Antimicrobial Resistance
Poster
P-2-16
Enterococcus faecium ST117/CT71 are predominantly present in Germany and less in other European countries
Prof. Dr. Linda Falgenhauer (Giessen/ DE)
Antimicrobial Resistance
Poster
P-2-17
Epidemiology of fungal drug resistance in Germany
Laman Rahimli (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-18
Evaluation of inhibitors against Energy-coupling factor (ECF) transporters using a bacterial uptake assay
Atanaz Shams (Saarbrücken/ DE)
Antimicrobial Resistance
Poster
P-2-19
A study on clinical Citrobacter spp. isolates reveals a high proportion of ST396 isolates and a distinct sodium azide tolerance
Björn Bettinger (Giessen/ DE)
Antimicrobial Resistance
Poster
P-2-20
Knowledge, attitudes and practices related to antibiotics and awareness on antimicrobial resistance: a survey in the Asante Akim North District, Ghana
Elisenda Cama i Gibernau (Heidelberg/ DE)
Antimicrobial Resistance
Poster
P-2-21
Evaluation of FT-IRS compared to cgMLST for assessing strain-relatedness of vancomycin-resistant Enterococcus faecium
Dr. Paul Higgins (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-22
Comparative genomic analysis of vancomycin-resistant Enterococcus faecium isolates from Germany with a focus on the Rhine-Main area reveals an unexpected vanA/vanB ratio
Tom Kurjak (Giessen/ DE)
Antimicrobial Resistance
Poster
P-2-23
A genome-based epidemiological survey of Escherichia coli in bloodstream infections and surveillance samples in Germany, 2016-2018, reveals the presence of a supra-regional clone with One Health relevance
Prof. Dr. Linda Falgenhauer (Giessen/ DE)
Antimicrobial Resistance
Poster
P-2-24
Exploitation of peptidoglycan hydrolases of the MepM family as novel antivirulence and resistance breaking targets (TTU GI 06.823)
Dr. rer. nat. Fabian Renschler (Tübingen/ DE)
Antimicrobial Resistance
Poster
P-2-25
Phage decolonization of Enterococcus faecium in an in vitro gut system
Dr. Thomas Fließwasser (Bonn/ DE)
Antimicrobial Resistance
Poster
P-2-26
Extremely short-lived peptide-polyene antimicrobial enables nasal commensal to eliminate Staphylococcus aureus
Dr. Bernhard Krismer (Tübingen/ DE)
Antimicrobial Resistance
Poster
P-2-27
Analyzing the metabolic phenotypes of the multi-drug resistant Gram-negative pathogens A. baumannii and K. pneumoniae using systems biology
Nantia Leonidou (Tübingen/ DE)
Antimicrobial Resistance
Poster
P-2-28
Transcriptional regulation of natural compound synthesis in the myxobacterium Sorangium sp.
Dr. Judith Boldt (Braunschweig/ DE)
Antimicrobial Resistance
Poster
P-2-29
Insights into the diversity and fitness of the potential nasal probiotic Corynebacterium accolens
Ahmed M.A. Elsherbini (Tübingen/ DE)
Antimicrobial Resistance
Poster
P-2-30
In-patient dynamics of intestinal vancomycin-resistant enterococci, microbiota alterations and association with environmental spread in haematological and oncological patients
Dr. Lena M. Biehl (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-31
Prevalence of ESBL enterobacteria, Campylobacter sp and Arcobacter sp in the stool of the poultry in Nouna, Burkina Faso
Dr. Dramane Kiemde (Nouna/ BF)
Antimicrobial Resistance
Poster
P-2-32
The Global AMR R&D Hub: global knowledge centre and driving force for evidence-based AMR advocacy
Usha Lamichhane (Berlin/ DE)
Antimicrobial Resistance
Poster
P-2-33
Phylogenetic strain classification, resistance prediction, and cluster analysis of tuberculosis isolates from Lambaréné, Gabon
Prof. Dr. Martin P. Grobusch (Amsterdam/ NL)
Antimicrobial Resistance
Poster
P-2-34
Investigation of tuberculostearic acid containing phosphatidylinositols and their metabolism in culture systems and in samples of patients suffering from tuberculosis
Dr. Nadine Aboutara (Borstel/ DE)
Antimicrobial Resistance
Poster
P-2-35
Global gene regulation in multi-drug resistant Acinetobacter baumannii; RNAseq using the MinION platform
Aime Picornell (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-36
One Health perspectives of Antimicrobial Resistance (AMR) and Antimicrobial Use (AMU) – data availability from sub-Saharan Africa: a systematic review
Dr. Primrose Beryl (Tübingen/ DE)
Antimicrobial Resistance
Poster
P-2-37
Targeting elastase LasB in Pseudomonas aeruginosa: a biological study on a new class of phosphonate-based inhibitors
Roya Shafiei (Saarbrücken/ DE)
Antimicrobial Resistance
Poster
P-2-38
A multicenter study comparing the molecular epidemiology of vancomycin-resistant and vancomycin-susceptible Enterococcus faecium bloodstream isolates in Germany
Dr. Kyriaki Xanthopoulou (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-39
The TTU-TB Drug Quantitation Platform
PD Dr. Dominik Schwudke (Borstel/ DE)
Antimicrobial Resistance
Poster
P-2-40
Facile production of the Pseudomonas aeruginosa virulence factor LasB in E. coli for structure-based drug design
Dominik Kolling (Saarbrücken/ DE)
Antimicrobial Resistance
Poster
P-2-42
Frequency of Acinetobacter species isolated from clinical samples over a 34-month period
Dr. Paul Higgins (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-43
Split k-mer analysis of the vancomycin-resistant Enterococcus faecium CT71 endemic clone from Germany
Dr. Kyriaki Xanthopoulou (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-44
The influence of established and novel antibiotics on the activity of the WalRK and LiaRS two-component systems of Bacillus subtilis
Maike Karcher (Bonn/ DE)
Antimicrobial Resistance
Poster
P-2-45
MraY from Pseudomonas aeruginosa is inhibited by uridyl-peptide antibiotics
Jan-Martin Daniel (Bonn/ DE)
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
Poster
P-2-46
High-throughput screening of the EU-OPENSCREEN compound library in search of novel antituberculars
Emmanuel Tola Adeniyi (Cologne/ DE)
Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
Poster
P-2-47
Is today's TDM still valid tomorrow? – Assessment of the inter-occasional variability of second-line TB drugs (IOVA-TB)
Niklas Köhler (Borstel/ DE)
Antimicrobial Resistance
Poster
P-2-48
Linezolid-resistant Enterococcus faecium bloodstream isolates from Germany: molecular epidemiology and resistance mechanisms
Dr. David Tobys (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-49
Evaluation of the RESIST-ACINETO immunochromatographic test for the rapid detection of OXA-23/-40/58-like and NDM carbapenemase-producing Acinetobacter spp.
Dr. Alexander Klimka (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-50
HelicoPTER – Regional prevalence and antibiotic resistance of Helicobacter pylori infection in Germany
Lukas Macke (Munich/ DE)
Antimicrobial Resistance
Poster
P-2-51
Characterisation of carbapenem-resistance in carbapenemase-negative Klebsiella pneumoniae for development of an antibody-based rapid detection kit
Liza Marie Maus (Cologne/ DE)
Antimicrobial Resistance
Poster
P-2-52
High-throughput sequencing technologies for genome methylation analysis and possible epigenetic intervention strategies in the model bacterium Helicobacter pylori
Prof. Christine Josenhans (Munich/ DE)
Antimicrobial Resistance
Poster
P-2-53
Kidney involvement in schistosomiasis
Alex Serge Siebner (Tübingen/ DE)
Tropical and Emerging Infections
Poster
P-2-54
Unraveling the viral genomic determinants of Ebola virus persistence
Glaucia Herzer (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-55
Generation and in vitro characterization of two recombinant MVA candidate vaccines expressing Marburg virus glycoprotein or nucleoprotein
Dr. Alina Tscherne (Oberschleißheim/ DE)
Tropical and Emerging Infections
Poster
P-2-56
Impact of Wuchereria bancrofti infection on cervical mucosal immunity of women in Lindi, Tanzania
PD Dr. med. Inge Kroidl (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-57
A human lung organoid platform for infectious disease modelling
Karla A. Schwenke (Berlin/ DE)
Tropical and Emerging Infections
Poster
P-2-58
A soluble version of Nipah virus glycoprotein G delivered by vaccinia virus MVA activates specific CD8 and CD4 T cells in mice
Dr. Georgia Kalodimou (Oberschleißheim/ DE)
Tropical and Emerging Infections
Poster
P-2-59
Infection dynamics of arboviruses in wild birds in Germany (2021/2022)
Franziska Schopf (Greifswald - Insel Riems/ DE)
Tropical and Emerging Infections
Poster
P-2-60
Ultrasound assessment of hepatosplenic schistosomiasis: an experience in a highly endemic area of Madagascar
Dr. Valentina Marchese (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-61
SARS-CoV-2 Nsp3 a.a.1-1363 down-regulates antiviral factors p53 and p63 by targeting RCHY1
Yi Ru (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-62
Corallopyronin A: successful non-GLP in vivo toxicity tests in rat and dog support continued development to first in human trials
Andrea Schiefer (Bonn/ DE)
Tropical and Emerging Infections
Poster
P-2-63
Mpox-specific T-cell responses in HIV-infected individuals after vaccination and infection
Eva Grüner (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-64
Characterization of dendritic cells from the multimammate mouse (Mastomys natalensis) and their immune profile in response to Lassa Virus infection
Nicolas Corrales (Berlin/ DE)
Tropical and Emerging Infections
Poster
P-2-65
Adaption of SARS-CoV-2 to mycophenolic acid-mediated depletion of intracellular GTP pools
Dr. Toni Luise Meister (Bochum/ DE)
Tropical and Emerging Infections
Poster
P-2-66
Establishment and characterization of two Crimean-Congo hemorrhagic fever virus animal models in mice
Dr. Cornelius Rohde (Marburg/ DE)
Tropical and Emerging Infections
Poster
P-2-67
Cyclophilins are involved in SARS-CoV-2 replication and cellular innate immune response
Pengyuan Li (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-68
Employing machine learning on large scale perturbation screens for SARS-CoV-2 host factors identifies PRI-724 interfering β-catenin/CBP interaction as a new antiviral
Prof. Dr. Rainer Koenig (Jena/ DE)
Tropical and Emerging Infections
Poster
P-2-69
Identification of the role of histone deacetylase 1 during SARS-CoV-2 infection
Dr. Chengyu Xiang (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-70
Rescue and characterization of the first West African Marburg virus from Guinea
Isabel von Creytz (Marburg/ DE)
Tropical and Emerging Infections
Poster
P-2-71
Genetically attenuated blood stage vaccines against malaria
David Markovic Lubotsky (Heidelberg/ DE)
Tropical and Emerging Infections
Poster
P-2-72
Establishment of a multiplex digital PCR to detect MVA-based vaccines in human plasma
Ruben Baumann (Hamburg/ DE)
Immune Prevention and Therapy
Poster
P-2-73
The use of novel assays for point of care samples to diagnose childhood TB disease – a multi-centre prospective study in Low Middle-income countries
Dr. Laura Olbrich (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-74
Development of a preclinical model for human mpox disease using skin scarification in CAST/Eij
Dr. Lisa-Marie Schünemann (Hannover/ DE)
Tropical and Emerging Infections
Poster
P-2-75
Prevalence of viremia in SARS-CoV-2 patients from the NAPKON cohort
Dr. Katharina Grikscheit (Frankfurt a. M./ DE)
Tropical and Emerging Infections
Poster
P-2-76
Neurological deficits due to brain abscesses caused by disseminated infection with mycobacterium bovis
Dr. Katrin Knoflach (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-77
Utility of live-attenuated measles virus to generate immunogenic anti-bunyavirus vaccines
Dr. Mohamed Rasheed Gadalla (Langen/ DE)
Tropical and Emerging Infections
Poster
P-2-78
Socioeconomic inequalities in health outcomes among mothers their children and: insights from the malaria birth cohort, Agogo, Ghana
Solomon Tsebeni Wafula (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-79
Clinical and pathogenetic features of acute kidney injury in Lassa fever patients at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
Matin Kohsar (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-80
Role of tumor necrosis factor superfamily member 10 (TNFSF10) in SARS-CoV2-infection-associated lung damage
Irina Kuznetsova (Giessen/ DE)
Tropical and Emerging Infections
Poster
P-2-81
Prevalence of schistosome infection among infants in rural highlands of Madagascar: a cross-sectional study
Irina Kislaya (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-82
Analyzing the humoral immune response to mpox using a bead-based multiplex orthopoxvirus immunoassay
Daniel Junker (Reutlingen/ DE)
Tropical and Emerging Infections
Poster
P-2-83
Commensal rodent pathogen diversity
Calvin Mehl (Greifswald - Insel Riems/ DE)
Tropical and Emerging Infections
Poster
P-2-84
Diagnosing urinary and intestinal schistosomiasis in adults from Malagasy areas with medium to high endemicity
Dr. Eva Lorenz (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-85
Development of a live-attenuated monkeypox virus for use in improved diagnostics
Vincent Klatt (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-86
Reporter-virus-based screening for novel anti-Lassa virus drugs
Dr. Lisa Oestereich (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-87
SARS-CoV-2 nonstructural protein 3 targets Makorin Ring Finger Protein 2 to disturb host antiviral responses
Dr. Yue Ma-Lauer (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-88
The Antiviral Compound Testing Platform (ACTP) and its application to identify broad-spectrum antivirals
Dr. Heeyoung Kim (Heidelberg/ DE)
Tropical and Emerging Infections
Poster
P-2-89
Mechanistic characterization of novel antiviral compounds (PROTACs) against SARS-CoV-2
You-Ting Chen (Braunschweig/ DE)
Tropical and Emerging Infections
Poster
P-2-90
Performance of point of care diagnostic for Schistosoma mansoni in areas with different endemicity in Ghana and Tanzania
PD Dr. med. Inge Kroidl (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-91
Health and developmental status of children from a prospective birth cohort in Agogo, Ghana
Dr. Nicole Gilberger (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-92
Development of a novel point-of-care diagnostic test for schistosomiasis
Clarissa Prazeres da Costa (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-93
Targeting Schistosoma mansoni microRNA with small molecules to modulate host-parasite interactions
Clarissa Prazeres da Costa (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-94
Identification of a novel anti-schistosomal multi-stage Component X derived from mouse serum
Clarissa Prazeres da Costa (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-95
A novel SARS-CoV-2 replicon system expressing a secreted luciferase and the GFP-zeocin fusion protein
Dr. Susanne Pfefferle (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-96
Highly heterogenous clinical presentation of patients with extrapulmonary tuberculosis enrolled in the DZIF EX-TB-study
Dr. Angela Klingmüller (Cologne/ DE)
Tropical and Emerging Infections
Poster
P-2-97
Identifying novel antiviral small molecules and their targets in coronavirus-infected cells
Talia Samara Schneider (Hannover/ DE)
Tropical and Emerging Infections
Poster
P-2-98
Development of a physiologically based biopharmaceutics model for CorA and prediction of human pharmacokinetics and effective dose using enhanced formulation
Jan Heitkötter (Bonn/ DE)
Tropical and Emerging Infections
Poster
P-2-99
Development of a repeated batch process for the Corallopyronin A production
Miriam Grosse (Braunschweig/ DE)
Tropical and Emerging Infections
Poster
P-2-100
Clinical performance evaluation of a real-time PCR kit for the detection of Lassa virus
Dr. Ndapewa Ithete (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-101
Diagnostic qRT-PCR as screening assays of antiviral compounds against highly pathogenic RNA viruses
Dr. Gesche Gerresheim (Marburg/ DE)
Tropical and Emerging Infections
Poster
P-2-102
System serology in Lassa fever survivors from Edo State, Nigeria
Solvej Oberhof (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-103
In vitro characterization and optimization of antiviral aerosol therapy against SARS-CoV-2 and other respiratory viruses
Christin Müller (Giessen/ DE)
Tropical and Emerging Infections
Poster
P-2-104
Mpox: evaluation of immune responses induced after infection versus vaccination
Dr. Hanna-Marie Weichel (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-105
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike induce differential S1- and S2-specific immune responses in humans
Leonie Mayer (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-106
Whole blood gene expression signatures define disease severity in extrapulmonary tuberculosis – implications for transcriptomics based biomarkers
Dr. Isabelle Suárez (Cologne/ DE)
Tropical and Emerging Infections
Poster
P-2-107
Paediatric Migrant and Public Health Center Munich (PMPH) – improving tuberculosis (TB) care for children in the context of migration: preliminary results and evaluation
Marta Alustiza (Munich/ DE)
Tropical and Emerging Infections
Poster
P-2-108
The TAKeOFF LEDoxy trials: two randomized controlled clinical trials to evaluate the effectiveness of intensified hygiene measures with or without doxycycline for the treatment of patients with lymphedema due to lymphatic filariasis
Dr. Ute Klarmann-Schulz (Bonn/ DE)
Tropical and Emerging Infections
Poster
P-2-109
Follow-up of survivors of Lassa Fever in Edo State, Nigeria: studies of correlates of immunity
Dr. David M. Wozniak (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-2-110
Children lack antibodies in saliva and plasma after primary Omicron infection
Constanze Heinzel (Tübingen/ DE)
Tropical and Emerging Infections
Poster
P-2-111
Psychiatric symptoms and delirium in acute Lassa fever - a cross-sectional study in Edo State, Nigeria
Dr. Charlotte Kriebel* (Hamburg/ DE)
Tropical and Emerging Infections
Poster
P-1-78
Dissecting humoral immune responses to the MVA-MERS-S vaccine candidate using a systems serology approach
Leonie M. Weskamm (Hamburg/ DE)
Immune Prevention and Therapy